Results
eNauka >
Results >
CYP2C19 slow metabolizer phenotype is associated with lower antidepressant efficacy and tolerability
| Title: | CYP2C19 slow metabolizer phenotype is associated with lower antidepressant efficacy and tolerability | Authors: | Joković, Danilo; Milosavljević, Filip |
Issue Date: | 2022 | Publication: | Psychiatry Research | ISSN: | 0165-1781 Psychiatry Research Search Idenfier |
Publisher: | Limerick : Elsevier/North-Holland Biomedical Press | Type: | Article | Collation: | vol. 312 br. (114535) str. 114535-114535 | DOI: | 10.1016/j.psychres.2022.114535 | WoS-ID: | 000821199300009 | Scopus-ID: | 2-s2.0-85127725861 | URI: | https://enauka.gov.rs/handle/123456789/465219 https://farfar.pharmacy.bg.ac.rs/handle/123456789/4080 |
Project: | PsyCise - Utility of Plasma Drug Level Monitoring and Cyp2c19/Cyp2d6 Genotyping in Dose Personalization of Antidepressants and Antipsychotics (RS-6066800) MFVMA/05/20–22 grant from the University of Defense, Belgrade, Serbia |
M-category: | 21a+M21a+ |